DOCSLIB.ORG

Lp(A) in Hypertensive Patients

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Lp(A) in Hypertensive Patients Journal of Human Hypertension (1998) 12, 83–89 1998 Stockton Press. All rights reserved 0950-9240/98 $12.00 ORIGINAL ARTICLE Lp(a) in hypertensive patients M Catalano1, E Perilli1, G Carzaniga1, F Colombo2, M Carotta1 and S Andreoni1 1Research Center on Vascular Diseases; 2Department of Internal Medicine, University of Milan, L. Sacco Hospital, Milan, Italy Lipoprotein(a) (Lp(a)) is considered an important risk trations of Lp(a), total cholesterol (TC), triglycerides factor for coronary disease, cerebrovascular pathology (TG) and very low density lipoprotein (VLDL-C) than and re-stenosis of coronary bypass. Few studies have controls (P Ͻ 0.01), with no differences in the plasma been conducted on this lipoprotein in essential arterial concentrations of Lp(a) between the two sexes. Only 10 hypternsive patients. The purpose of our study was to hypertension patients and seven controls had plasma measure the serum concentrations of Lp(a) and the concentrations of Lp(a) of over 30 mg/dl. Lp(a) does not main parameters of the lipid profile in a group of essen- correlate with the main parameters of the lipid profile. tial hypertensive patients not receiving pharmacological We can confirm that hypertension and dyslipidaemia, treatment and with no clinical signs of associated which are two of the main risk factors for vascular dis- pathologies or organ damage. A total of 123 Caucasian eases on an atherosclerotic basis, are often associated. essential arterial hypertensive patients (47 men and 76 However, higher plasma concentrations of Lp(a), albeit women) were studied and compared with 89 controls (36 within the normal range, could be an independent risk men and 53 women) matched in terms of age, sex, body factor for atherosclerosis, and could contribute towards mass index (BMI) and smoking habits. It was found that increasing the incidence of cardiovascular disease in the hypertensive patients had higher plasma concen- people with essential arterial hypertension. Keywords: lipoprotein(a); total cholesterol; apolipoprotein; hypertension Introduction only associated with an increased risk of vascular diseases such as CHD24–31 and the re-stenosis of cor- Many studies have shown clearly that high concen- onary bypass32–35 but are also considered an inde- trations of low-density lipoproteins (LDL-C), Apoli- pendent risk factor for these pathologies. poprotein B (Apo B) and total cholesterol (TC) Up to now there is very little information on Lp(a) accompanied by low concentrations of high-density in hypertensive patients available in the literature, lipoproteins (HDL-C) and Apoprotein AI (Apo AI) and any results published are contrasting.36–41 are the main risk factors for coronary heart disease Therefore, the aim of our study was to measure 1–15 (CHD), and there is considerable evidence that the serum concentrations of lipoproteins, and in all measures which are capable of lowering LDL-C particular of Lp(a) in a group of untreated hyperten- and raising HDL-C concentrations also help to lower sive patients with no clinical signs of associated 16 the incidence of acute events in these patients. In pathologies or organ damage and no family histories patients with essential hypertension there are often of coronary or cerebrovascular atherosclerotic dis- cardiovascular risk factors. Indeed, in these patients, ease. a modification of the lipid profile has been observed, with increased levels of total cholesterol, triglycer- ides and LDL-C and low blood concentrations of Materials and methods 17–19 HDL-C. Patients The lipoprotein(a) Lp(a) was described for the first time in 1963 by Berg.20 It consists of a set of lipopro- A total of 123 Caucasian patients (47 men and 76 teins with different molecular weights (from 350 to women) with essential arterial hypertension [sys- 900 KD),21 in which particles of LDL are bonded to tolic blood pressure (SBP) 165 ± 1.5 mm Hg and apoprotein(a) (apo(a)), which has a kringle structure diastolic blood pressure (DBP) 101 ± 0.4 mm Hg] with a high level of homology to plasminogen.22,23 were studied. Their average age was 53 ± 9 and their The physiological function of this lipoprotein is still average body mass index (BMI) was 25.4 ± 3.9. They unknown but the importance attributed to it has included 14 smokers (11%), but no former smokers. increased considerably in the light of the evidence The diagnosis of essential hypertension was reached that high plasma concentrations of Lp(a) are not after repeatedly measuring the patients’ arterial pressure at different times of the day using a mer- cury sphygmomanometer (Korotkoff sounds I and V) Correspondence: Professor M Catalano, Research Center on Vas- after lying in a supine position for 10 min, consider- cular Diseases, University of Milan, L. Sacco Hospital, Via G.B. Ͻ Ͻ Grassi 74, 20157 Milano, Italy ing an SBP of 140 mm Hg and a DBP of 90 42 Received 22 April 1997; revised 3 July 1997; accepted 5 August mm Hg as normal pressure values. Any patients 1997 with secondary hypertension, a positive family his- Lp(a) in hypertensive patients M Catalano et al 84 tory of cardiovascular diseases, the presence of clini- ations for TC, TG, HDL were: TC 0.8–0.7%, TG 0.7– cally evident cardiovascular (coronary, cerebral, and 0.6% and HDL 1.05–1.32%, respectively. The LDL- peripheral vascular diseases) or tumoral disease; or C and VLDL-C lipoprotein fractions were obtained with electrocardiographic signs of angina, alteration using Friedewald’s formula Apo AI, AII and B were of the S-T segment, changes in T, sugar dysmetabol- determined by means of radioimmunodiffusion ism (fasting glycemia Ͼ110 mg/dl), BMI Ͼ30 kg/m2, (RID), using plates containing polyclonal antibodies disorders of the renal (creatinine Ͼ1.2 mg/dl), liver (Daichi, Tokyo, Japan).46 Lastly, Lp(a) was assayed (AST Ͼ25 IU/L, ALT Ͼ29 IU/L, total bilirubin using two different anti-Apo(a) antibodies, the first Ͼ1.2 mg/dl, ␥-GT Ͼ38 IU/L) or thyroid functions of which was a monoclonal solid-phase antibody, (TSH Ͻ0.5 ␮U/ml or 3.5 ␮U/ml) and uricemia while the second was polyclonal, and marked with Ͼ5.7 mg/dl for the female and Ͼ7 mg/dl for the male a peroxidase (Macra Enzyme Immunoassay kit: patients, were excluded. Terumo Medical Corporation, Strategic Diagnosis Eighty-nine Caucasian subjects (36 men and 53 Division, Elkton, MD 21921, USA).47 The inter- and women) with no clinically evident pathologies and intra-assay coefficients of variations for Lp(a) were originating from the same geographical area were 3.1–1.3%, respectively. The lowest measurable used as a control group. They were matched with Lp(a) concentration was calculated to be 0.8 mg/dl. the hypertensive patients in terms of age (51 ± 3), ± sex, BMI (24.8 3.4) and smoking habits (11 smok- Statistical analysis ers = 12%) (see Table 1). For the purpose of this study, the patients did not receive any drugs capable In order to choose the most appropriate statistical of altering their lipid profiles for at least 4 weeks test, the variables were tested for skewness. Thanks before taking the blood samples. They were given to this preliminary statistical evaluation, it was no dietary restrictions. The hypertensive patients established that, with the exception of Lp(a), all the and the controls all came from Medical Angiology variables in question had a sufficiently normal dis- or Internal Medicine out-patient departments. tribution. For this reason, the statistical analysis was perfor- med using analysis of variance (ANOVA) and Blood samples Tukey’s test, and in view of the skewed distribution The blood samples for determining the apolipoprot- of blood Lp(a) concentrations in the hypertensive ein profiles were taken at 8.00 am, without stasis, and normal subjects we applied the Mann–Whit- by inserting a needle into the vein after fasting and ney test. refraining from cigarette smoking for at least 12 h. The ␹2 test was used for the non-parametric vari- ables. Values of P Ͻ 0.05 were considered signifi- cant. Determination of the apolipoprotein profile The correlations between Lp(a) and all the The samples for determining the plasma concen- remaining parameters studied were checked using trations of total cholesterol, triglyceride, VLDL-C, the Spearman Correlation Test, taking Lp(a) as an LDL-C, HDL-C, Apoproteins AI, AII and B and Lp(a) independent variable. were placed in pre-cooled test tubes containing EDTA (1 mg/ml) and centrifuged immediately at Results 1500 g for 15 min at a temperature of 4°C. The plasma obtained in this way was then frozen and Table 1 describes the main clinical characteristics of stored at −85°C, and assayed within 2 weeks after the essential hypertensive patients and of the nor- sampling. TC and TG were assayed using enzyme mal controls. The two groups were similar in terms methods, with kits supplied by Boehringer of age, sex, smoking habits and BMI, while the aver- (Mannheim, Germany).43,44 The HDL-C concen- age systolic and diastolic BP values were higher in tration was measured after precipitation of the lipo- the patients with essential hypertension. proteins containing Apo B with phosphotungstic Table 2, on the other hand, shows the plasma con- acid and subsequent enzymatic assaying of choles- 45 Table 2 Apolipoprotein profile of normotensives and hyperten- terol. The inter- and intra-assay coefficients of vari- sives Parameters Normotensives Hypertensives P Table 1 Demographic data TC (mg/dl) 204.8 ± 33.1 220.0 ± 38.5 Ͻ0.01b Normotensives Hypertensives TG (mg/dl) 92.6 ± 40.5 128.3 ± 61.9 Ͻ0.01b HDL-C (mg/dl) 46.2 ± 10.7 47.5 ± 10.8 n.s.
Load more

Recommended publications
  • Orthostatic Hypotension in a Cohort of Hypertensive Patients Referring to a Hypertension Clinic
    Journal of Human Hypertension (2015) 29, 599–603 © 2015 Macmillan Publishers Limited All rights reserved 0950-9240/15 www.nature.com/jhh ORIGINAL ARTICLE Orthostatic hypotension in a cohort of hypertensive patients referring to a hypertension clinic C Di Stefano, V Milazzo, S Totaro, G Sobrero, A Ravera, A Milan, S Maule and F Veglio The prevalence of orthostatic hypotension (OH) in hypertensive patients ranges from 3 to 26%. Drugs are a common cause of non-neurogenic OH. In the present study, we retrospectively evaluated the medical records of 9242 patients with essential hypertension referred to our Hypertension Unit. We analysed data on supine and standing blood pressure values, age, sex, severity of hypertension and therapeutic associations of drugs, commonly used in the treatment of hypertension. OH was present in 957 patients (10.4%). Drug combinations including α-blockers, centrally acting drugs, non-dihydropyridine calcium-channel blockers and diuretics were associated with OH. These pharmacological associations must be administered with caution, especially in hypertensive patients at high risk of OH (elderly or with severe and uncontrolled hypertension). Angiotensin-receptor blocker (ARB) seems to be not related with OH and may have a potential protective effect on the development of OH. Journal of Human Hypertension (2015) 29, 599–603; doi:10.1038/jhh.2014.130; published online 29 January 2015 INTRODUCTION stabilization, and then at 1 and 3 min after standing. The average of the Orthostatic hypotension (OH) is defined as the reduction in blood last two SBP and DBP values measured in the supine position and the pressure (BP) of at least 20 mmHg systolic and/or 10 mm Hg lowest value during standing were considered.
    [Show full text]
  • Hypertension and the Prothrombotic State
    Journal of Human Hypertension (2000) 14, 687–690 2000 Macmillan Publishers Ltd All rights reserved 0950-9240/00 $15.00 www.nature.com/jhh REVIEW ARTICLE Hypertension and the prothrombotic state GYH Lip Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, UK The basic underlying pathophysiological processes related to conventional risk factors, target organ dam- underlying the major complications of hypertension age, complications and long-term prognosis, as well as (that is, heart attacks and strokes) are thrombogenesis different antihypertensive treatments. Further work is and atherogenesis. Indeed, despite the blood vessels needed to examine the mechanisms leading to this being exposed to high pressures in hypertension, the phenomenon, the potential prognostic and treatment complications of hypertension are paradoxically throm- implications, and the possible value of measuring these botic in nature rather than haemorrhagic. The evidence parameters in routine clinical practice. suggests that hypertension appears to confer a Journal of Human Hypertension (2000) 14, 687–690 prothrombotic or hypercoagulable state, which can be Keywords: hypercoagulable; prothrombotic; coagulation; haemorheology; prognosis Introduction Indeed, patients with hypertension are well-recog- nised to demonstrate abnormalities of each of these Hypertension is well-recognised to be an important 1 components of Virchow’s triad, leading to a contributor to heart attacks and stroke. Further- prothrombotic or hypercoagulable state.4 Further- more, effective antihypertensive therapy reduces more, the processes of thrombogenesis and athero- strokes by 30–40%, and coronary artery disease by 2 genesis are intimately related, and many of the basic approximately 25%. Nevertheless the basic under- concepts thrombogenesis can be applied to athero- lying pathophysiological processes underlying both genesis.
    [Show full text]
  • Major Clinical Considerations for Secondary Hypertension And
    & Experim l e ca n i t in a l l C Journal of Clinical and Experimental C f a o r d l i a o Thevenard et al., J Clin Exp Cardiolog 2018, 9:11 n l o r g u y o Cardiology DOI: 10.4172/2155-9880.1000616 J ISSN: 2155-9880 Review Article Open Access Major Clinical Considerations for Secondary Hypertension and Treatment Challenges: Systematic Review Gabriela Thevenard1, Nathalia Bordin Dal-Prá1 and Idiberto José Zotarelli Filho2* 1Santa Casa de Misericordia Hospital, São Paulo, Brazil 2Department of scientific production, Street Ipiranga, São José do Rio Preto, São Paulo, Brazil *Corresponding author: Idiberto José Zotarelli Filho, Department of scientific production, Street Ipiranga, São José do Rio Preto, São Paulo, Brazil, Tel: +5517981666537; E-mail: [email protected] Received date: October 30, 2018; Accepted date: November 23, 2018; Published date: November 30, 2018 Copyright: ©2018 Thevenard G, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Introduction: In this context, secondary arterial hypertension (SH) is defined as an increase in systemic arterial pressure (SAP) due to an identifiable cause. Only 5 to 10% of patients suffering from hypertension have a secondary form, while the vast majorities have essential hypertension. Objective: This study aimed to describe, through a systematic review, the main considerations on secondary hypertension, presenting its clinical data and main causes, as well as presenting the types of treatments according to the literary results.
    [Show full text]
  • How to Document and Code for Hypertensive Diseases in ICD-10 THIS INSTALLMENT in FPM’S ICD-10 SERIES EXPLAINS the GUIDELINES for CODING HYPERTENSION
    How to Document and Code for Hypertensive Diseases in ICD-10 THIS INSTALLMENT IN FPM’S ICD-10 SERIES EXPLAINS THE GUIDELINES FOR CODING HYPERTENSION. Kenneth D. Beckman, MD, MBA, CPE, CPC ecause ICD-10 can be a distressing topic, let’s start or kidney disease. That code is I10, Essential (primary) with some good news: Hypertension has a limited hypertension. number of ICD-10 codes – only nine codes for pri- As in ICD-9, this code includes “high blood pressure” mary hypertension and five codes for secondary but does not include elevated blood pressure without a B hypertension. This makes the task of coding hypertension diagnosis of hypertension (that would be ICD-10 code relatively simple – well, at least compared to some of the R03.0). If a patient has progressed from elevated blood other ICD-10 complexities. pressure to a formal diagnosis of hypertension, a good Another positive change in ICD-10 is that the new documentation practice would be to include the reason for code set drops the previous reference to benign and progressing the formal diagnosis. Similarly, a single mildly malignant hypertension. As physicians, we are well aware elevated blood pressure reading should be coded with the that hypertension is never truly “benign,” and the removal R03.0 until the formal diagnosis is established. of this antiquated term is a welcome improvement in the Although various sources define hypertension slightly lexicon of diseases. differently, the provider should document elevated systolic But, of course, nothing is easy in ICD-10, and there are pressure above 140 or diastolic pressure above 90 with at several things you need to be aware of before we dig into least two readings on separate office visits.
    [Show full text]
  • Hypertensive Emergencies Are Associated with Elevated Markers of Inflammation, Coagulation, Platelet Activation and fibrinolysis
    Journal of Human Hypertension (2013) 27, 368–373 & 2013 Macmillan Publishers Limited All rights reserved 0950-9240/13 www.nature.com/jhh ORIGINAL ARTICLE Hypertensive emergencies are associated with elevated markers of inflammation, coagulation, platelet activation and fibrinolysis U Derhaschnig1,2, C Testori2, E Riedmueller2, S Aschauer1, M Wolzt1 and B Jilma1 Data from in vitro and animal experiments suggest that progressive endothelial damage with subsequent activation of coagulation and inflammation have a key role in hypertensive crisis. However, clinical investigations are scarce. We hypothesized that hypertensive emergencies are associated with enhanced inflammation, endothelial- and coagulation activation. Thus, we enrolled 60 patients admitted to an emergency department in a prospective, cross-sectional study. We compared markers of coagulation, fibrinolysis (prothrombin fragment F1 þ 2, plasmin–antiplasmin complexes, plasmin-activator inhibitor, tissue plasminogen activator), platelet- and endothelial activation and inflammation (P-selectin, C-reactive protein, leukocyte counts, fibrinogen, soluble vascular adhesion molecule-1, intercellular adhesion molecule-1, myeloperoxidase and asymmetric dimethylarginine) between hypertensive emergencies, urgencies and normotensive patients. In hypertensive emergencies, markers of inflammation and endothelial activation were significantly higher as compared with urgencies and controls (Po0.05). Likewise, plasmin–antiplasmin complexes were 75% higher in emergencies as compared with urgencies (Po0.001), as were tissue plasminogen-activator levels (B30%; Po0.05) and sP-selectin (B40%; Po0.05). In contrast, similar levels of all parameters were found between urgencies and controls. We consistently observed elevated markers of thrombogenesis, fibrinolysis and inflammation in hypertensive emergencies as compared with urgencies. Further studies will be needed to clarify if these alterations are cause or consequence of target organ damage.
    [Show full text]
  • Quality ID #236 (NQF 0018): Controlling High Blood Pressure
    Quality ID #236 (NQF 0018): Controlling High Blood Pressure – National Quality Strategy Domain: Effective Clinical Care – Meaningful Measure Area: Management of Chronic Conditions 2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Intermediate Outcome – High Priority DESCRIPTION: Percentage of patients 18 - 85 years of age who had a diagnosis of hypertension and whose blood pressure was adequately controlled (< 140/90 mmHg) during the measurement period INSTRUCTIONS: This measure is to be submitted a minimum of once per performance period for patients with hypertension seen during the performance period. The performance period for this measure is 12 months. The most recent quality code submitted will be used for performance calculation. This measure may be submitted by Merit-based Incentive Payment System (MIPS) eligible clinicians who perform the quality actions described in the measure based on the services provided and the measure-specific denominator coding. NOTE: In reference to the numerator element, only blood pressure readings performed by a clinician in the provider office are acceptable for numerator compliance with this measure. Do not include blood pressure readings that meet the following criteria: • Blood pressure readings from the patient's home (including readings directly from monitoring devices). • Taken on the same day as a diagnostic test or diagnostic or therapeutic procedure that requires a change in diet or change in medication on or one day before the day of the test or procedure, with the exception of fasting blood tests. If no blood pressure is recorded during the measurement period, the patient’s blood pressure is assumed “not controlled”. Measure Submission Type: Measure data may be submitted by individual MIPS eligible clinicians, groups, or third party intermediaries.
    [Show full text]
  • An Approach to the Young Hypertensive Patient
    CME ARTICLE An approach to the young hypertensive patient P Mangena,1 MB ChB, FCP (SA); S Saban,2 MB ChB, MFamMed, FCFP (SA); K E Hlabyago,3 BSc (Education), MSc, MB ChB, MMed (Family Medicine); B Rayner,1 MB ChB, MMed, FCP (SA), PhD 1 Division of Nephrology and Hypertension, Faculty of Health Sciences, Groote Schuur Hospital and University of Cape Town, South Africa 2 Private Practice, and Division of Family Medicine, School of Public Health and Family Medicine, Faculty of Health Sciences, University of Cape Town, South Africa 3 Department of Family Medicine, Dr George Mukhari Academic Hospital and Sefako Makgatho Health Sciences University, Pretoria, South Africa Corresponding author: P Mangena ([email protected]) Hypertension is the leading cause of death worldwide. Globally and locally there has been an increase in hypertension in children, adolescents and young adults <40 years of age. In South Africa, the first decade of the millennium saw a doubling of the prevalence rate among adolescents and young adults aged 15 ­ 24 years. This increase suggests that an explosion of cerebrovascular disease, cardiovascular disease and chronic kidney disease can be expected in the forthcoming decades. A large part of the increased prevalence can be attributed to lifestyle factors such as diet and physical inactivity, which lead to overweight and obesity. The majority (>90%) of young patients will have essential or primary hypertension, while only a minority (<10%) will have secondary hypertension. We do not recommend an extensive workup for all newly diagnosed young hypertensives, as has been the practice in the past. We propose a rational approach that comprises a history to identify risk factors, an examination that establishes the presence of target­organ damage and identifies clues suggesting secondary hypertension, and a limited set of basic investigations.
    [Show full text]
  • Arteriolosclerosis : a Consideration of the Pathology and Etiology
    University of Nebraska Medical Center DigitalCommons@UNMC MD Theses Special Collections 5-1-1934 Arteriolosclerosis : a consideration of the pathology and etiology Joseph K. Orr University of Nebraska Medical Center This manuscript is historical in nature and may not reflect current medical research and practice. Search PubMed for current research. Follow this and additional works at: https://digitalcommons.unmc.edu/mdtheses Part of the Medical Education Commons Recommended Citation Orr, Joseph K., "Arteriolosclerosis : a consideration of the pathology and etiology" (1934). MD Theses. 344. https://digitalcommons.unmc.edu/mdtheses/344 This Thesis is brought to you for free and open access by the Special Collections at DigitalCommons@UNMC. It has been accepted for inclusion in MD Theses by an authorized administrator of DigitalCommons@UNMC. For more information, please contact [email protected]. ARTERIOLOSCI,EROSIS A Consideration of the Pathology & Etiology Joseph Knight Orr Senior Thesis-April 1934 INTRODUCTION This thesis is presented ae a review of certain facts and theories pertaining to a branch of one of the most interesting and disputed subjects in the field of medicine today. In the light of modern scientific and medical advancement Arterial Sclerosis furnishes a very fertile field for the development of knowledge. In addition, this branch of Arteriosclerosis is intimately tied up with Hypertension--another enigma of medicine. These two afflictions have for many years been subjects of bitter and profound controversy, and rightfully so, for both - are processes which seem to be ultimately connected with our common heritage: Senility and Death. These arguments have resulted in establishing definite fields of investigation t and in an assortment of facts.
    [Show full text]
  • Hypertensive Emergencies: an Update Paul E
    Hypertensive emergencies: an update Paul E. Marika and Racquel Riverab aDepartment of Medicine, Eastern Virginia Medical Purpose of review School and bDepartment of Pharmacy, Sentara Norfolk General Hospital, Norfolk, Virginia, USA Systemic hypertension (HTN) is a common medical condition affecting over 1 billion people worldwide. One to two percent of patients with HTN develop acute elevations of Correspondence to Paul E. Marik, MD, FCCP, FCCM, Eastern Virginia Medical School, 825 Fairfax Avenue, blood pressure (hypertensive crises) that require medical treatment. However, only Suite 410, Norfolk, VA 23507, USA patients with true hypertensive emergencies require the immediate and controlled E-mail: [email protected] reduction of blood pressure with an intravenous antihypertensive agent. Current Opinion in Critical Care 2011, Recent findings 17:569–580 Although the mortality from hypertensive emergencies has decreased, the prevalence and demographics of this disorder have not changed over the last 4 decades. Clinical experience and reported data suggest that patients with hypertensive urgencies are frequently inappropriately treated with intravenous antihypertensive agents, whereas patients with true hypertensive emergencies are overtreated with significant complications. Summary Despite published guidelines, most patients with hypertensive crises are poorly managed with potentially severe outcomes. Keywords aortic dissection, clevidipine, eclampsia, esmolol, hypertension, hypertensive emergencies, labetalol, nicardipine, pulmonary edema Curr Opin Crit Care 17:569–580 ß 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins 1070-5295 of hypertension (compared to the previous four stages in Introduction JNC VI). In addition, a new category called prehyper- Systemic hypertension (HTN) is a common medical tension was added. Hypertension is defined as a SBP condition affecting over 1 billion people worldwide greater than 140 mmHg or a DBP greater than 90 mmHg and more than 65 million Americans [1,2].
    [Show full text]
  • Essential Hypertension*
    BRmSw 30 October 1965 MEDICAL JOURNAL 1021 Br Med J: first published as 10.1136/bmj.2.5469.1021 on 30 October 1965. Downloaded from Hyperpiesis: High Blood-pressure without Evident Cause: Essential Hypertension* Sir GEORGE PICKERINGt M.D., D.SC., F.R.C.P., F.R.S. Brit. med.J_., 1965, 2, 1021-1026 Benign Hypertension that there is a third factor not in the coronary arteries and not the arterial pressure which contributes to hypertensive heart The benign phase of hypertension offers a great contrast to the disease. Could it possibly be related to advancing years, the malignant phase. The course is long and variable, with the disorder described by William Dock (1945) as presbycardia ? condition often remaining unchanged for years; thus, of As Fig. 12 shows, heart weight and arterial pressure are related Bechgaard's original 1,038 patients, 357 were alive after 20 quantitatively. Since, as Shirley Smith and Fowler (1955) and years (llechgaard et al., 1956). Bechgaard (unpublished) has Hamilton (1956) have shown, heart failure can be relieved and recently reported that 144 were alive after 26 to 32 years. prevented by lowering pressure, and since heart size decreases Uraemia does not occur; bilateral neuroretinopathy does not (Smirk, 1957), there is a strong case for supposing that elevation occur; cerebral oedema does not occur, or occurs only rarely; of arterial pressure is a causal factor in the cardiac changes. patients tend to die of heart failure, cerebral vascular disease, or intercurrent disease. Its nature is clearly different. The malignant phase is characterized by lesions which Cerebral Vascular Disease represent the limit of cardiovascular tolerance, fibrinoid arteriolar necrosis, retinal exudates representing focal vascular Cerebral vascular disease is still something of a morass.
    [Show full text]
  • Essential Hypertension
    University of Nebraska Medical Center DigitalCommons@UNMC MD Theses Special Collections 5-1-1931 Essential hypertension Kaname Yoshimura University of Nebraska Medical Center This manuscript is historical in nature and may not reflect current medical research and practice. Search PubMed for current research. Follow this and additional works at: https://digitalcommons.unmc.edu/mdtheses Part of the Medical Education Commons Recommended Citation Yoshimura, Kaname, "Essential hypertension" (1931). MD Theses. 188. https://digitalcommons.unmc.edu/mdtheses/188 This Thesis is brought to you for free and open access by the Special Collections at DigitalCommons@UNMC. It has been accepted for inclusion in MD Theses by an authorized administrator of DigitalCommons@UNMC. For more information, please contact [email protected]. SEN lOB THE SIS U N I V E R SIT Y o F NEB R ASK A 1 931 E 8 8 E N T I A L H Y PER TEN T ION KANAME' Y 0 8 HIM U R a ESSENTIAL HYPERTENTION I1'IITRODUCT10N During my service at the dispensary in the senior ~;fsc~f.I;'1 year,I was impressed with the frequency of so-called hyperten- 1 tion. Reading an artiole," The Age and Sex Inoidence of Essen- tial Hypertention", by Riseman and \Veiss, The American Heart Journal,Vol.V,No.2 : l72-l89,Deo.1929,my interest in the sub- ject was fUrther increased. In this paper , the known faots and the main theor­ ies conoerning Essential Hypertention in the ourtrent literature are briefly discussed and arranged in the following order :- 1 - Definition 2 - Normal Blood Pressure 3 - Frequenoy 4 - Probable Etiology 5 - Pathogenesis 6 ';"Uiorbii Ana tomy and Pathology 7 - Symptoms 8 - Prognosis 9 - Treatment 10 - Conolusion 0) DEFINITION Essential Hypertention ( latent angiosclerosis,hyper­ piesis, presclerosis, benign essential hypertention ) is a pro- gressive disease of unknown etiology,probably beginning in the second decade of life and ending usually in the third decade,by cardiac failure, cerebral accidents,or renal insufficiency.
    [Show full text]
  • Genetic Epidemiology of Essential Hypertension
    Journal of Human Hypertension (1999) 13, 225–229 1999 Stockton Press. All rights reserved 0950-9240/99 $12.00 http://www.stockton-press.co.uk/jhh ORIGINAL ARTICLE Genetic epidemiology of essential hypertension I Gavras1, A Manolis1,2 and H Gavras1 1Hypertension and Atherosclerosis Section of the Department of Medicine, Boston University School of Medicine, Boston, MA, USA; 2Tzanio Hospital, Piraeus, Greece This review article is intended to introduce the unini- heritable anthropometric, clinical or biochemical tiated clinician to the basic concepts, aims and early characteristics; and some applications of genetic epi- findings of the genetic epidemiology of hypertension. It demiologic techniques, such as linkage and association separates the rare monogenic ‘Mendelian’ hypertensive studies of certain gene polymorphisms with hyperten- disorders from the vast majority of patients with essen- sion using affected sibling pairs and large sibships or tial hypertension, which is a complex, polygenic, multi- wide genomic screens comparing affected and unaffec- factorial disorder resulting from interaction of several ted populations. Although so far there is no genotypic genes with each other and with the environment. It high- variation proven to be causally related to essential lights some clinical strategies used to enhance hypertension, its intermediate phenotypes or any of its searches for ‘candidates genes’, such as subgrouping complications, it is hoped that new, more efficient of populations into relatively homogenous groups or methods of genetic analysis will yield clinically mean- ‘intermediate phenotypes’ according to presumably ingful information. Keywords: gene polymorphisms; candidate genes; monogenic disorders; intermediate phenotypes; polygenic multifactorial traits Hypertensive phenotypes the interaction of several genes with each other and with the environment result in different phenotypes.
    [Show full text]